Indian pharma and MedTech stakeholders are urging the government to expand the Production-Linked Incentive (PLI) scheme to cover critical APIs and reduce import duties on advanced radiotherapy equipment — aimed […]
Market research data shows that cardiac medications recorded the highest sales in India in 2025, driven by rising non-communicable diseases such as hypertension, lipid disorders, and heart failure. The cardiac […]
The 2026 Union Budget outlines a strategic shift for India’s pharmaceutical and medical device sectors, moving from high-volume, low-value production to higher-value manufacturing and innovation-led growth. The policy direction aims […]
A new Indian AI Research Organisation (IAIRO)will be established in GIFT City as a public-private initiative to advance AI R&D across sectors including healthcare. With an initial budget of ₹300 […]
French pharma giant Sanofi agreed to buy U.S. biotech Dynavax Technologies for about $2.2 billion, as it strengthens its vaccine and specialty medicine portfolio. The deal underlines the continued strategic […]
Novo Nordisk’s oral Wegovy (GLP-1) pill has been approved by the US FDA, marking the first time this class of drug is available in pill form — a major convenience […]
Emcure Pharmaceuticals has launched Poviztra, a once-weekly GLP-1-based injectable for weight management — its second collaboration with Danish firm Novo Nordisk. The drug will be available in multiple dosage strengths […]
An Indian pharmaceutical major has recently entered into a strategic global partnership to expand its presence in cancer immunotherapy, marking another step in the industry’s gradual move beyond traditional generics. […]
Marking a significant step toward global recognition and export growth of Indian traditional health products. The move is expected to strengthen bilateral trade while opening new international markets for evidence-based […]
India’s pharmaceutical exports reached $30.47 billion in FY2024-25, growing 9.4 % year-on-year, driven by strong manufacturing and widening global demand. India remains the world’s third-largest pharma producer by volume and […]